1. Home
  2. SIFY vs AVLN Comparison

SIFY vs AVLN Comparison

Compare SIFY & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sify Technologies Limited

SIFY

Sify Technologies Limited

HOLD

Current Price

$13.17

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$27.03

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIFY
AVLN
Founded
1995
2011
Country
India
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
1999
2026

Fundamental Metrics

Financial Performance
Metric
SIFY
AVLN
Price
$13.17
$27.03
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $62.25
AVG Volume (30 Days)
29.4K
★ 224.2K
Earning Date
10-26-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$66.06
N/A
Revenue Next Year
$18.27
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.09
$24.90
52 Week High
$17.85
$40.17

Technical Indicators

Market Signals
Indicator
SIFY
AVLN
Relative Strength Index (RSI) 39.16 32.76
Support Level $12.10 $25.86
Resistance Level $14.38 $30.45
Average True Range (ATR) 0.48 2.25
MACD -0.02 -0.56
Stochastic Oscillator 28.24 8.41

Price Performance

Historical Comparison
SIFY
AVLN

About SIFY Sify Technologies Limited

Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: